A randomised, double-blind, placebo-controlled crossover study to assess the efficacy of a single dose of 100mg of VRP700 by inhalation in reducing the frequency and severity of cough in adult patients with Idiopathic Pulmonary Fibrosis
Latest Information Update: 17 Jun 2016
At a glance
- Drugs VRP 700 (Primary)
- Indications Cough
- Focus Therapeutic Use
- Sponsors Verona Pharma
- 18 Apr 2014 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network record.
- 03 Dec 2013 New trial record